Idioma:

Bladder Cancer: Diagnosis and Treatment

DeGeorge, Katharine C ; Holt, Harry R ; Hodges, Stephanie C

American family physician, 2017-10, Vol.96 (8), p.507-514 [Periódico revisado por pares]

United States: American Academy of Family Physicians

Texto completo disponível

Citações Citado por

Enviar para

Título:
Bladder Cancer: Diagnosis and Treatment
Autor: DeGeorge, Katharine C ; Holt, Harry R ; Hodges, Stephanie C
Assuntos: Administration, Intravesical ; Adult ; Age ; Aged ; Antineoplastic Agents - administration & dosage ; Asymptomatic ; BCG Vaccine - administration & dosage ; Biomarkers ; Biomarkers, Tumor - blood ; Bladder cancer ; Cancer therapies ; Cellular biology ; Chemotherapy ; Chemotherapy, Adjuvant ; Classification ; Cystectomy ; Diabetes ; Family medical history ; Female ; Hematuria ; Human papillomavirus ; Humans ; Infections ; Male ; Medical diagnosis ; Metastasis ; Middle Aged ; Nocturia ; Pathology ; Patients ; Risk Assessment ; Risk factors ; Tumors ; United States ; Urinary Bladder Neoplasms - blood ; Urinary Bladder Neoplasms - diagnosis ; Urinary Bladder Neoplasms - therapy ; Urine ; Urogenital system ; Womens health
É parte de: American family physician, 2017-10, Vol.96 (8), p.507-514
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Descrição: Bladder cancer is the sixth most prevalent malignancy in the United States and causes more than 16,000 deaths annually. The most common clinical presentation is asymptomatic hematuria, which should prompt evaluation with cystoscopy, renal function testing, and upper urinary tract imaging in adults 35 years and older and in those with irritative voiding symptoms, risk factors for bladder cancer, or gross hematuria at any age. Transurethral resection of the bladder tumor allows for definitive diagnosis, staging, and primary treatment. Non-muscle-invasive disease is treated with transurethral resection, most often followed by intravesical bacille Calmette-Guérin or intravesical chemotherapy. Bladder cancer that invades the muscle layer is typically treated with radical cystectomy and neoadjuvant chemotherapy because of higher rates of progression and recurrence. No major organization recommends screening asymptomatic adults for bladder cancer, and the U.S. Preventive Services Task Force concluded that current evidence is insufficient to assess the balance of benefits and harms of screening.
Editor: United States: American Academy of Family Physicians
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Bladder Cancer: Diagnosis and Treatment

DeGeorge, Katharine C ; Holt, Harry R ; Hodges, Stephanie C

United States: American Academy of Family Physicians

Buscando em bases de dados remotas. Favor aguardar.